CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malats, N.
Right arrow Articles by Boffetta, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malats, N.
Right arrow Articles by Boffetta, P.
Cancer Epidemiology Biomarkers & Prevention Vol. 9, 827-833, August 2000
© 2000 American Association for Cancer Research

Lung Cancer Risk in Nonsmokers and GSTM1 and GSTT1 Genetic Polymorphism1

Núria Malats2, Anne-Marie Camus-Radon, Fredrik Nyberg, Wolfgang Ahrens, Vali Constantinescu, Anush Mukeria, Simone Benhamou, Halina Batura-Gabryel, Irene Bruske-Hohlfeld, Lorenzo Simonato, Ana Menezes, Suzanne Lea, Matti Lang and Paolo Boffetta

International Agency for Research on Cancer, F-69372 Lyon, France [N. M., A-M. C-R., S. L., M. L., P. B.]; Institut Municipal d’Investigació Mèdica, E-08003 Barcelona, Spain [N. M.]; Institute of Environmental Medicine, Karolinska Institute, S-17177 Stockholm, Sweden [F. N.]; Bremen Institute for Prevention Research, D-28199 Bremen, Germany [W.A.]; Institute of Public Health, R-76256 Bucharest, Romania [V. C.]; Institute of Carcinogenesis, Cancer Research Center, 115478 Moscow, Russia [A. Mu.]; INSERM U157, F-94805 Villejuif, France [S. B.]; Pneumological Hospital, 60-568 Poznan, Poland [H. B-G.]; GSF Institute for Epidemiology, D-85758 Munich, Germany [I. B-H.]; Veneto Cancer Registry, Department of Oncology, University of Padua, I-35128 Padua, Italy [L. S.]; Federal University of Rio Grande do Sul, 96100 Pelotas, RG, Brazil [A. Me.]; School of Public Health, University of California, Berkeley, California 94720-7360 [S. L.]; and Uppsala University, S-75123 Uppsala, Sweden [M. L.]

Glutathione S-transferase (GST) polymorphism may contribute to the individual variability in detoxifying lung carcinogens. This effect might be particularly relevant at low-level exposure to environmental carcinogens, such as in nonsmokers exposed to environmental tobacco smoke (ETS). We conducted a case-control study among 122 nonsmoking lung cancer cases and 121 nonsmoking controls from eight countries. Information on environmental exposures was obtained through a personal interview. The presence of GSTM1 and GSTT1 genes was determined using multiplex PCR. GSTM1-positive samples were then analyzed for *1A and *1B polymorphism using an allele-specific amplification-PCR method. GSTM1*2 (null) individuals had an odds ratio (OR) of lung cancer of 1.5 [95% confidence interval (CI), 0.9–2.7]; the risk associated with this genotype was higher for cases with squamous and small cell carcinomas (OR, 2.3; 95% CI, 0.9–6.1) than for cases with adenocarcinomas. It was also elevated in individuals with long-term exposure to indoor wood combustion (OR, 3.1; 95% CI, 0.9–9.9), in subjects who mainly lived in a rural setting (OR, 3.6; 95% CI, 1.0–13), and in cases exposed to occupational carcinogens (OR, 10.7; 96% CI, 0.4–260) but not in subjects exposed to ETS. GSTT1*2 subjects did not show a risk of lung cancer. Our study suggests that the effect of GSTM1 polymorphism in nonsmokers is similar to that found in smokers. It does not seem to interact with ETS exposure, although we cannot exclude that it does in association with exposure to other specific environmental carcinogens.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins
Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis
Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
R. Taylor, F. Najafi, and A. Dobson
Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent
Int. J. Epidemiol., October 1, 2007; 36(5): 1048 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S Raimondi, V Paracchini, H Autrup, J. Barros-Dios, S Benhamou, P Boffetta, M. Cote, I. Dialyna, V Dolzan, R Filiberti, et al.
Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review
Am. J. Epidemiol., December 1, 2006; 164(11): 1027 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Pisani, P. Srivatanakul, J. Randerson-Moor, S. Vipasrinimit, S. Lalitwongsa, P. Unpunyo, S. Bashir, and D. T. Bishop
GSTM1 and CYP1A1 Polymorphisms, Tobacco, Air Pollution, and Lung Cancer: A Study in Rural Thailand.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 667 - 674.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Orozco-Levi, J. Garcia-Aymerich, J. Villar, A. Ramirez-Sarmiento, J. M. Anto, and J. Gea
Wood smoke exposure and risk of chronic obstructive pulmonary disease.
Eur. Respir. J., March 1, 2006; 27(3): 542 - 546.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. J. Mazzone, J. C. Chagoya, and A. C. Arroliga
Cause and Effect in Lung Cancer: Fueling the Fire
Chest, July 1, 2005; 128(1): 6 - 8.
[Full Text] [PDF]


Home page
BMJHome page
P Vineis, L Airoldi, F Veglia, L Olgiati, R Pastorelli, H Autrup, A Dunning, S Garte, E Gormally, P Hainaut, et al.
Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study
BMJ, February 5, 2005; 330(7486): 277.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.S. Wenzlaff, M.L. Cote, C.H. Bock, S.J. Land, and A.G. Schwartz
GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study
Carcinogenesis, February 1, 2005; 26(2): 395 - 401.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Georgiadis, J. Topinka, D. Vlachodimitropoulos, M. Stoikidou, M. Gioka, G. Stephanou, H. Autrup, N. A. Demopoulos, K. Katsouyanni, R. Sram, et al.
Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations
Carcinogenesis, January 1, 2005; 26(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Cohet, S. Borel, F. Nyberg, A. Mukeria, I. Bruske-Hohlfeld, V. Constantinescu, S. Benhamou, P. Brennan, J. Hall, and P. Boffetta
Exon 5 Polymorphisms in the O6-Alkylguanine DNA Alkyltransferase Gene and Lung Cancer Risk in Non-Smokers Exposed to Second-Hand Smoke
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 320 - 323.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
G. Davey Smith
Effect of passive smoking on health
BMJ, May 15, 2003; 326(7398): 1048 - 1049.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
R. J. Hung, P. Boffetta, J. Brockmoller, D. Butkiewicz, I. Cascorbi, M. L. Clapper, S. Garte, A. Haugen, A. Hirvonen, S. Anttila, et al.
CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis
Carcinogenesis, May 1, 2003; 24(5): 875 - 882.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Stucker, A. Hirvonen, I. de Waziers, A. Cabelguenne, K. Mitrunen, S. Cenee, E. Koum-Besson, D. Hemon, P. Beaune, and M.-A. Loriot
Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility
Carcinogenesis, September 1, 2002; 23(9): 1475 - 1481.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Benhamou, W. J. Lee, A.-K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewicz, J. Brockmoller, M. L. Clapper, A. Daly, V. Dolzan, et al.
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk
Carcinogenesis, August 1, 2002; 23(8): 1343 - 1350.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. P. Miller, G. Liu, I. De Vivo, T. J. Lynch, J. C. Wain, L. Su, and D. C. Christiani
Combinations of the Variant Genotypes of GSTP1, GSTM1, and p53 Are Associated with an Increased Lung Cancer Risk
Cancer Res., May 1, 2002; 62(10): 2819 - 2823.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Garte, L. Gaspari, A.-K. Alexandrie, C. Ambrosone, H. Autrup, J. L. Autrup, H. Baranova, L. Bathum, S. Benhamou, P. Boffetta, et al.
Metabolic Gene Polymorphism Frequencies in Control Populations
Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1239 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. Stucker, P. Boffetta, S. Antilla, S. Benhamou, A. Hirvonen, S. London, and E. Taioli
Lack of Interaction between Asbestos Exposure and Glutathione S-Transferase M1 and T1 Genotypes in Lung Carcinogenesis
Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1253 - 1258.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Lewis, P. Brennan, F. Nyberg, W. Ahrens, V. Constantinescu, A. Mukeria, S. Benhamou, H. Batura-Gabryel, I. Bruske-Hohlfeld, L. Simonato, et al.
Re: Spitz, M. R., Duphorne, C. M., Detry, M. A., Pillow, P. C., Amos, C. I., Lei, L., de Andrade, M., Gu, X., Hong, W. K., and Wu, X. Dietary Intake of Isothiocyanates: Evidence of a Joint Effect with Glutathione S-Transferase Polymorphisms in Lung Cancer Risk. Cancer Epidemiol. Biomark. Prev., 9: 1017-1020, 2000
Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1105 - 1106.
[Full Text] [PDF]


Home page
Cancer Res.Home page
B. Pignatelli, C.-Q. Li, P. Boffetta, Q. Chen, W. Ahrens, F. Nyberg, A. Mukeria, I. Bruske-Hohlfeld, C. Fortes, V. Constantinescu, et al.
Nitrated and Oxidized Plasma Proteins in Smokers and Lung Cancer Patients
Cancer Res., January 1, 2001; 61(2): 778 - 784.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2000 by the American Association for Cancer Research.